4//SEC Filing
HARDY REGINALD L 4
Accession 0000819050-21-000125
CIK 0000819050other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:43 PM ET
Size
10.3 KB
Accession
0000819050-21-000125
Insider Transaction Report
Form 4
HARDY REGINALD L
DirectorChairman of the Board
Transactions
- Purchase
Common Stock
2021-07-26$0.67/sh+100,000$67,420→ 448,411 total - Purchase
Common Stock
2021-07-23$0.66/sh+100,000$66,230→ 348,411 total
Holdings
- 9,261(indirect: By Spouse)
Common Stock
- 17,260(indirect: By Trust)
Common Stock
- 21,826(indirect: By Spouse)
Common Stock
- 266,447(indirect: By Self as General Partner)
Common Stock
- 17,260(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents the purchase of 100,000 shares in multiple transactions, ranging in price from $0.66 to $0.6720 per share, resulting in a weighted average purchase price of $0.6623. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
- [F2]Represents the purchase of 100,000 shares in multiple transactions, ranging in price from $0.671 to $0.678 per share, resulting in a weighted average purchase price of $0.6742. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
Documents
Issuer
Brickell Biotech, Inc.
CIK 0000819050
Entity typeother
Related Parties
1- filerCIK 0001008105
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 4:43 PM ET
- Size
- 10.3 KB